Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafet Basar

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Molecular Therapy. Methods & Clinical Development|July 7, 2025
Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cellsTaha B Hayal, Aman A Mulla, David S J Allan, et al.
Cytotherapy|August 8, 2016
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyAbdullah Alsuliman, Stanley H Appel, David R Beers, et al.
Genome Biology|May 9, 2022
Bi-order multimodal integration of single-cell dataJinzhuang Dou, Shaoheng Liang, Vakul Mohanty, et al.
Leukemia|August 8, 2022
A phase two study of high dose blinatumomab in Richter's syndromePhilip A Thompson, Xianli Jiang, Pinaki Banerjee, et al.
Iscience|July 3, 2024
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profilesShan He, Matthew M Gubin, Hind Rafei, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profilesShan He, Matthew M Gubin, Hind Rafei, et al.
Frontiers in Immunology|January 30, 2018
Evidence for B Cell Exhaustion in Chronic Graft-versus-Host DiseaseAhmad Khoder, Abdullah Alsuliman, Rafet Basar, et al.
Journal for Immunotherapy of Cancer|July 26, 2022
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signalingSamantha M Fix, Marie-Andrée Forget, Donastas Sakellariou-Thompson, et al.
Transplantation and Cellular Therapy|December 2, 2023
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin LymphomaYago Nieto, Pinaki Banerjee, Indresh Kaur, et al.
Frontiers in Immunology|November 9, 2018
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood TransplantationKai Cao, David Marin, Takuye Sekine, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Molecular Therapy. Methods & Clinical Development|July 7, 2025
Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cellsTaha B Hayal, Aman A Mulla, David S J Allan, et al.
Cytotherapy|August 8, 2016
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyAbdullah Alsuliman, Stanley H Appel, David R Beers, et al.
Genome Biology|May 9, 2022
Bi-order multimodal integration of single-cell dataJinzhuang Dou, Shaoheng Liang, Vakul Mohanty, et al.
Leukemia|August 8, 2022
A phase two study of high dose blinatumomab in Richter's syndromePhilip A Thompson, Xianli Jiang, Pinaki Banerjee, et al.
Iscience|July 3, 2024
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profilesShan He, Matthew M Gubin, Hind Rafei, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profilesShan He, Matthew M Gubin, Hind Rafei, et al.
Frontiers in Immunology|January 30, 2018
Evidence for B Cell Exhaustion in Chronic Graft-versus-Host DiseaseAhmad Khoder, Abdullah Alsuliman, Rafet Basar, et al.
Journal for Immunotherapy of Cancer|July 26, 2022
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signalingSamantha M Fix, Marie-Andrée Forget, Donastas Sakellariou-Thompson, et al.
Transplantation and Cellular Therapy|December 2, 2023
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin LymphomaYago Nieto, Pinaki Banerjee, Indresh Kaur, et al.
Frontiers in Immunology|November 9, 2018
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood TransplantationKai Cao, David Marin, Takuye Sekine, et al.
Pageof 6